Covered recipient · General Payments record
HENRY STANGER DUST
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2023–2024
$311.40
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.30 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $56.45 | 2 |
| Janssen Biotech, Inc. | $38.97 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $34.10 | 2 |
| ABBVIE INC. | $17.43 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.43 | 1 |
| Celgene Corporation | $15.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.43 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103670306 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.05 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146963001 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.05 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147024650 | CMS |
| Celgene Corporation | $15.92 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101164332 | CMS |
| Janssen Biotech, Inc. | $17.95 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078760487 | CMS |
| Janssen Biotech, Inc. | $21.02 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078760387 | CMS |
| Lilly USA, LLC | $33.79 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135018914 | CMS |
| Lilly USA, LLC | $22.66 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134999690 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.43 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137536538 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.